$3.10
0.061.97%
At Close: -
$3.10
00.00%
After Hours: 4:44 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $50.21M | Get Alert |
03/05/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $48.10M | Get Alert |
11/06/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $47.00M | $50.00M | $47.45M | Get Alert |
08/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $44.00M | $48.00M | $43.37M | Get Alert |
05/02/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $42.00M | $46.00M | $39.06M | Get Alert |
03/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $37.00M | $41.00M | $37.83M | Get Alert |
11/01/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $47.01M | Get Alert |
08/02/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $46.46M | Get Alert |
05/03/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $48.01M | Get Alert |
03/08/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $62.68M | Get Alert |
11/02/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $47.00M | $49.00M | $48.32M | Get Alert |
08/03/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $46.00M | $48.00M | $40.07M | Get Alert |
05/04/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $38.00M | $42.00M | $39.13M | Get Alert |
03/09/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $38.00M | $42.00M | $41.19M | Get Alert |
11/04/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $42.00M | $46.00M | $47.32M | Get Alert |
08/04/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $35.00M | $45.00M | $38.42M | Get Alert |
05/05/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $35.00M | $45.00M | $41.40M | Get Alert |
03/11/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $35.00M | $45.00M | $43.86M | Get Alert |
01/10/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $35.00M | $45.00M | $56.85M | Get Alert |
01/10/2020 | AQST | Aquestive Therapeutics | FY | 2019 | — | — | — | $52.00M | $52.00M | $46.36M | Get Alert |
01/10/2020 | AQST | Aquestive Therapeutics | Q4 | 2019 | — | — | — | $16.00M | $16.00M | $10.23M | Get Alert |
11/05/2019 | AQST | Aquestive Therapeutics | FY | 2019 | — | — | — | $45.00M | $47.00M | $43.69M | Get Alert |
There have been no specific sales or earnings guidance reported for Aquestive Therapeutics in recent months.
Browse guidance and forecast on all stocks.